XTX Topco Ltd Has $26,000 Position in Palatin Technologies, Inc. (NYSEAMERICAN:PTN)

XTX Topco Ltd boosted its position in shares of Palatin Technologies, Inc. (NYSEAMERICAN:PTN) by 98.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,063 shares of the biopharmaceutical company’s stock after acquiring an additional 14,432 shares during the period. XTX Topco Ltd’s holdings in Palatin Technologies were worth $26,000 at the end of the most recent quarter.

Separately, Armistice Capital LLC bought a new stake in Palatin Technologies in the 2nd quarter valued at $3,272,000. Institutional investors and hedge funds own 11.50% of the company’s stock.

Analyst Ratings Changes

Separately, HC Wainwright reaffirmed a “buy” rating and set a $17.00 price objective on shares of Palatin Technologies in a report on Thursday.

Palatin Technologies Stock Performance

NYSEAMERICAN PTN opened at $0.97 on Monday. Palatin Technologies, Inc. has a 1-year low of $0.68 and a 1-year high of $5.65. The company has a market cap of $18.92 million, a price-to-earnings ratio of -0.49 and a beta of 0.90.

Palatin Technologies (NYSEAMERICAN:PTN) last announced its quarterly earnings results on Tuesday, October 1st. The biopharmaceutical company reported ($0.51) EPS for the quarter. On average, sell-side analysts predict that Palatin Technologies, Inc. will post -1.66 EPS for the current year.

About Palatin Technologies

Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.